98 related articles for article (PubMed ID: 2702653)
1. Early metabolic response to tumor necrosis factor in mouse sarcoma: a phosphorus-31 nuclear magnetic resonance study.
Shine N; Palladino MA; Patton JS; Deisseroth A; Karczmar GS; Matson GB; Weiner MW
Cancer Res; 1989 Apr; 49(8):2123-7. PubMed ID: 2702653
[TBL] [Abstract][Full Text] [Related]
2. Acute effects of tumor necrosis factor alpha or lymphotoxin on global blood flow, laser Doppler flux, and bioenergetic status of subcutaneous rodent tumors.
Kluge M; Elger B; Engel T; Schaefer C; Seega J; Vaupel P
Cancer Res; 1992 Apr; 52(8):2167-73. PubMed ID: 1559220
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the antitumor activities of human tumor necrosis factor-alpha and the comparison with other cytokines: induction of tumor-specific immunity.
Palladino MA; Shalaby MR; Kramer SM; Ferraiolo BL; Baughman RA; Deleo AB; Crase D; Marafino B; Aggarwal BB; Figari IS
J Immunol; 1987 Jun; 138(11):4023-32. PubMed ID: 3295044
[TBL] [Abstract][Full Text] [Related]
4. Modulation of murine radiation-induced fibrosarcoma-1 tumor metabolism and blood flow in situ via glucose and mannitol administration monitored by 31P and 2H nuclear magnetic resonance spectroscopy.
Hwang YC; Kim SG; Evelhoch JL; Seyedsadr M; Ackerman JJ
Cancer Res; 1991 Jun; 51(12):3108-18. PubMed ID: 1904001
[TBL] [Abstract][Full Text] [Related]
5. Selective depletion of tumor ATP by 2-deoxyglucose and insulin, detected by 31P magnetic resonance spectroscopy.
Karczmar GS; Arbeit JM; Toy BJ; Speder A; Weiner MW
Cancer Res; 1992 Jan; 52(1):71-6. PubMed ID: 1727388
[TBL] [Abstract][Full Text] [Related]
6. Flavone acetic acid (NSC 347512)-induced modulation of murine tumor physiology monitored by in vivo nuclear magnetic resonance spectroscopy.
Evelhoch JL; Bissery MC; Chabot GG; Simpson NE; McCoy CL; Heilbrun LK; Corbett TH
Cancer Res; 1988 Sep; 48(17):4749-55. PubMed ID: 3409216
[TBL] [Abstract][Full Text] [Related]
7. Dietary fat modulation of murine mammary tumor metabolism studied by in vivo 31P-nuclear magnetic resonance spectroscopy.
Buckman DK; Erickson KL; Ross BD
Cancer Res; 1987 Nov; 47(21):5631-6. PubMed ID: 3664470
[TBL] [Abstract][Full Text] [Related]
8. 31P-nuclear magnetic resonance studies of the effect of recombinant human interleukin 1 alpha on the bioenergetics of RIF-1 tumors.
Constantinidis I; Braunschweiger PG; Wehrle JP; Kumar N; Johnson CS; Furmanski P; Glickson JD
Cancer Res; 1989 Nov; 49(22):6379-82. PubMed ID: 2804984
[TBL] [Abstract][Full Text] [Related]
9. Nuclear magnetic resonance analysis of tumor necrosis factor-induced alterations of phospholipid metabolites and pH in Friend leukemia cell tumors and fibrosarcomas in mice.
Podo F; Carpinelli G; Di Vito M; Giannini M; Proietti E; Fiers W; Gresser I; Belardelli F
Cancer Res; 1987 Dec; 47(24 Pt 1):6481-9. PubMed ID: 3677088
[TBL] [Abstract][Full Text] [Related]
10. 31P-nuclear magnetic resonance spectroscopy studies of the response of rat mammary tumors to endocrine therapy.
Rodrigues LM; Midwood CJ; Coombes RC; Stevens AN; Stubbs M; Griffiths JR
Cancer Res; 1988 Jan; 48(1):89-93. PubMed ID: 3335001
[TBL] [Abstract][Full Text] [Related]
11. Development of partial tolerance to the gastrointestinal effects of high doses of recombinant tumor necrosis factor-alpha in rodents.
Patton JS; Peters PM; McCabe J; Crase D; Hansen S; Chen AB; Liggitt D
J Clin Invest; 1987 Dec; 80(6):1587-96. PubMed ID: 3500186
[TBL] [Abstract][Full Text] [Related]
12. Angiogenesis determines blood flow, metabolism, growth rate, and ATPase kinetics of tumors growing in an irradiated bed: 31P and 2H nuclear magnetic resonance studies.
Okunieff P; Dols S; Lee J; Singer S; Vaupel P; Neuringer LJ; Beshah K
Cancer Res; 1991 Jun; 51(12):3289-95. PubMed ID: 1710169
[TBL] [Abstract][Full Text] [Related]
13. Open-chest 31P magnetic resonance spectroscopy of mouse heart at 4.7 Tesla.
Lee J; Hu Q; Nakamura Y; Wang X; Zhang X; Zhu X; Chen W; Yang Q; Zhang J
J Magn Reson Imaging; 2006 Dec; 24(6):1269-76. PubMed ID: 17096395
[TBL] [Abstract][Full Text] [Related]
14. PEGylated recombinant human tumor necrosis factor alpha: preparation and anti-tumor potency.
Li YP; Pei YY; Ding J; Shen ZM; Zhang XY; Gu ZH; Zhou JJ
Acta Pharmacol Sin; 2001 Jun; 22(6):549-55. PubMed ID: 11747763
[TBL] [Abstract][Full Text] [Related]
15. Measurements of in vivo 31P nuclear magnetic resonance spectra in neuroectodermal tumors for the evaluation of the effects of chemotherapy.
Naruse S; Hirakawa K; Horikawa Y; Tanaka C; Higuchi T; Ueda S; Nishikawa H; Watari H
Cancer Res; 1985 Jun; 45(6):2429-33. PubMed ID: 3986784
[TBL] [Abstract][Full Text] [Related]
16. Early onset of rejection in concordant hamster xeno hearts display signs of necrosis, but not apoptosis, correlating to the phosphocreatine concentration.
Lukes DJ; Tivesten A; Wilton J; Lundgren A; Rakotonirainy O; Kjellström C; Isgaard J; Karlsson-Parra A; Soussi B; Olausson M
Transpl Immunol; 2003; 12(1):29-40. PubMed ID: 14551030
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneous metabolic changes in the calf muscle of the rat during ischaemia-reperfusion: in vivo analysis by 31P nuclear magnetic resonance chemical shift imaging and 1H magnetic resonance imaging.
Morikawa S; Inubushi T; Kito K
Cardiovasc Surg; 1993 Aug; 1(4):337-42. PubMed ID: 8076056
[TBL] [Abstract][Full Text] [Related]
18. 31P nuclear magnetic resonance spectroscopy studies of tumor energy metabolism and its relationship to intracapillary oxyhemoglobin saturation status and tumor hypoxia.
Rofstad EK; DeMuth P; Fenton BM; Sutherland RM
Cancer Res; 1988 Oct; 48(19):5440-6. PubMed ID: 3416301
[TBL] [Abstract][Full Text] [Related]
19. Murine mammary tumor response to hyperthermia and radiotherapy evaluated by in vivo 31P-nuclear magnetic resonance spectroscopy.
Sijens PE; Bovée WM; Seijkens D; Koole P; Los G; van Rijssel RH
Cancer Res; 1987 Dec; 47(24 Pt 1):6467-73. PubMed ID: 3677087
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of tumor high-energy phosphate metabolism by insulin combined with rhodamine 123.
Arbeit JM; Toy BJ; Karczmar GS; Hubesch A; Weiner MW
Surgery; 1988 Aug; 104(2):161-70. PubMed ID: 3041641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
